以上内容来自Benzinga Earnings专栏,原文如下:
Corcept Therapeutics (NASDAQ:CORT) reported quarterly earnings of $0.26 per share which missed the analyst consensus estimate of $0.42 by 38.1 percent. This is a 7.14 percent decrease over earnings of $0.28 per share from the same period last year. The company reported quarterly sales of $181.900 million which missed the analyst consensus estimate of $198.686 million by 8.45 percent. This is a 34.34 percent increase over sales of $135.405 million the same period last year.
精彩评论